Tetra Bio-Pharma Overview

  • Founded
  • 2007

Founded
  • Status
  • Public

  • Employees
  • 33

Employees
  • Stock Symbol
  • TBP

Stock Symbol
  • Investments
  • 8

  • Share Price
  • $0.05

  • (As of Wednesday Closing)

Tetra Bio-Pharma General Information

Description

Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

Contact Information

Formerly Known As
GrowPros Cannabis Ventures
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
TSE
Primary Office
  • 2316 Saint Joseph Boulevard
  • Orleans, Ontario K1C 1E8
  • Canada
+1 (343) 000-0000

Tetra Bio-Pharma Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tetra Bio-Pharma Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.05 $0.04 - $0.26 $19.7M 423M 279K -$0.07

Tetra Bio-Pharma Financials Summary

In Thousands,
USD
TTM 28-Feb-2022 FY 2021 30-Nov-2021 FY 2020 30-Nov-2020 FY 2019 30-Nov-2019
EV 24,616 64,932 31,703 55,124
Revenue 0 0 0 0
EBITDA (34,627) (40,078) (15,775) (9,885)
Net Income (36,259) (41,594) (19,686) (11,494)
Total Assets 6,895 5,926 22,595 21,497
Total Debt 2,076 2,442 1,540 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tetra Bio-Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tetra Bio-Pharma‘s full profile, request access.

Request a free trial

Tetra Bio-Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical program
Drug Discovery
Orleans, Canada
33 As of 2021
000.00
000000000 000.00

000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 000000000
London, United Kingdom
0 As of 0000
0000
00.00 0000-00-00
00000000 0000

00000

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
00000 000000000000000 000 0000000000000
Vancouver, Canada
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tetra Bio-Pharma Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxford Cannabinoid Technologies Formerly VC-backed London, United Kingdom 0 0000 00000000 0000
00000 00000000 00. Corporation Vancouver, Canada 00.000 000000000 00.000
000-000000 Corporation Toronto, Canada 00 000.00 000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Tetra Bio-Pharma Patents

Tetra Bio-Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3115179-A1 Cannabis compositions and methods Pending 18-Dec-2018 000000000
CA-3027876-A1 Cannabis compositions and methods Pending 18-Dec-2018 000000000
EP-3897615-A1 Cannabis compositions and methods Pending 18-Dec-2018 000000000
AU-2019409889-A1 Cannabis compositions and methods Pending 18-Dec-2018 A61K9/007

Tetra Bio-Pharma Executive Team (24)

Name Title Board Seat Contact Info
Guy Chamberland Ph.D Chief Executive Officer & Board Member
Melanie Kelly Ph.D Chief Scientific Officer
Natalie Leroux Director, Investor Relations
Randy Ringuette Ph.D Director, Manufacturing Sciences & Technology
Charles Campbell Director, Research & Development
You’re viewing 5 of 24 executive team members. Get the full list »

Tetra Bio-Pharma Board Members (8)

Name Representing Role Since
00000 000000 00 Self Chairman & Board Member 000 0000
0000 000000 Self Board Member 000 0000
000000000 0000 Tetra Bio-Pharma Board Member 000 0000
000 00000000000 00.0 Tetra Bio-Pharma Chief Executive Officer & Board Member 000 0000
0000 000 Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Tetra Bio-Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tetra Bio-Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tetra Bio-Pharma‘s full profile, request access.

Request a free trial

Tetra Bio-Pharma Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 (0000 0 03-Jun-2020 000000000 Drug Discovery 000000 0é
000 000000000 21-Aug-2019 00000 0000 Pharmaceuticals 000 00000
00000 000000 01-May-2019 0000000000 000.00 Drug Discovery 000 00000
00000 0000000 29-Apr-2019 00000 0000 Drug Delivery 000 00000
Phytopain Pharma 19-Mar-2018 Secondary Transaction - Private 000.00 Pharmaceuticals 0000000 0
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Tetra Bio-Pharma Subsidiaries (2)

Company Name Industry Location Founded
Panag Pharma Drug Discovery Halifax, Canada 2014
0000000 000000000 Gold Mining Ottawa, Canada 0000
To view Tetra Bio-Pharma’s complete subsidiaries history, request access »

Tetra Bio-Pharma Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 22-Jun-2016 000000000000000000 00000 Completed
  • 00000 000-000000
Export Hydro 06-Nov-2015 Merger/Acquisition 000 Completed
To view Tetra Bio-Pharma’s complete exits history, request access »